Prevalence, characteristic and hematologic profile of anemia cases among stunting children in a Jakarta Secondary Hospital
Abstract
Introduction: In 2022, WHO reported that 148.1 million children were stunting. Indonesia reported having a high number of stunting cases (31%) in 2022. While anemia is the most common comorbidity in stunting children, addressing these conditions requires comprehensive assessment. This study aims to determine and analyze the prevalence, characteristics, and hematological picture of anemia in stunting children.
Methods: A descriptive study conducted at Sumber Waras Hospital in West Jakarta, Indonesia in January-December 2023. The population was children aged 1–59 months in 2023, with a total 46 cases of stunting. The indicators assessed were sociodemographic, clinical and laboratory parameters, such as age, gender, weight, height, hemoglobin level, MCV, MCH, MCHC, hematocrit, erythrocytes, platelets, leukocytes, comorbidities, number of siblings, parental education, maternal occupation, mother's age, and economic status. The results were provided in descriptive analysis with an appropriate statistical approach.
Results: The prevalence of anemia in stunting children was 56.6%. The majority of anemia cases were mild (37%), while no severe anemia was observed. The respondents were predominantly male, aged below 24 months, 60.9% received exclusive breastfeeding, were born full term, and had a normal birth weight and length. The group of stunting children with anemia were mostly underweight, had more than 1 siblings, lower parents' educational backgrounds, mothers' ages around…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.